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Abstract
Background: Recent years have seen an increasing number of patients with multivessel
coronary artery disease and left ventricular systolic dysfunction being qualified for cardiac
surgery. Identification of patients who are likely to benefit most from revascularisation proce-
dures poses a considerable problem. The aim of the study was to assess the value of dobutamine
stress echocardiography in predicting the clinical course following coronary artery bypass
grafting (CABG) in patients with ischaemic left ventricular dysfunction.
Methods: Fifty patients with multivessel coronary artery disease and reduced left ventricular
ejection fraction (LVEF < 40%) who were qualified for CABG were included in the study.
Resting echocardiography and a small-dose (510 µg/kg/min) dobutamine test were performed
before the procedure. Subsequent tests were repeated after the procedure and at 3.6 and 12 months.
A combined endpoint of death, repeat hospitalisations, NYHA stage, severity of angina and left
ventricular systolic function was evaluated.
Results: Two factors were found to affect the prognosis adversely following CABG in both
univariate and multivariate analysis: a history of hypertension (p = 0.039, OR 4.9, 95% CI
1.417.1) and lack of improvement in contractility in at least 4 segments during the
dobutamine test (p = 0.0003, OR 37.2, 95% CI 6.3218.4). An improvement in contractility
in at least 4 segments of the left ventricle is the most important prognostic factor.
Conclusions: The results of the dobutamine stress test have a more potent prognostic value than
clinical or demographic parameters in predicting clinical improvement. Patients with negative
results of the test represent the group with the gravest prognosis. (Cardiol J 2007; 14: 174179)
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Introduction
Surgical revascularisation has significantly
improved the survival of patients with ischaemic
heart damage by reducing mortality by 25% and the
incidence of sudden cardiac death by half [1]. Left
ventricular dysfunction is the most common con-
sequence of coronary artery disease. In patients
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with areas of viable myocardium unfavourable left
ventricular remodelling after revascularisation pro-
cedures occurs less frequently [2].
In coronary artery disease, ventricular dysfunc-
tion may be a consequence of both the permanent
ventricular damage due to necrosis and fibrosis and
the presence of damaged but viable stunned myo-
cardium [3]. The term myocardial hibernation
refers to a long-term impairment of contractility,
most commonly as a result of chronic ischaemia.
Blood flow is usually high enough to keep the myo-
cytes alive but too low to meet fully the metabolic
demands associated with the normal contraction of
the heart muscle [4]. Evaluation of hibernated are-
as allows for a more precise stratification of the risks
and benefits in patients with ischaemic heart failure
undergoing coronary artery bypass grafting (CABG) [5].
The increased operative risk, which in patients
with low ejection fraction ranges from 11% to 16%,
is offset by the benefits resulting from the presence
of viable myocardium in the area subjected to revas-
cularisation [6]. It has been demonstrated that in pa-
tients with impaired left ventricular function but pre-
served viability the benefit of CABG is higher than
the benefit of conservative treatment [710]. The
diagnostic tests evaluating myocardial viability have
therefore become a necessary element of qualifica-
tion for revascularisation, especially in the case of
patients with low left ventricular ejection fraction.
The aim of the study was to identify the demo-
graphic and clinical parameters affecting the clini-
cal course in a one-year follow-up following CABG
and to establish the value of dobutamine stress
echocardiography in predicting postoperative clini-
cal improvement.
Methods
Characteristics of the patient group
The study included 50 patients (42 men and
8 women with a mean age of 60 years) hospitalised
at the Division of Cardiac Surgery of the Medical
University of Bia‡ystok, Poland between May 2002
and February 2004. All the patients met the follow-
ing inclusion criteria:
 chronic stable coronary artery disease;
 echocardiographically confirmed left ventricu-
lar systolic dysfunction: left ventricular ejec-
tion fraction (LVEF) below 40% (also con-
firmed in ventriculography);
 qualification of the patient for a revascularisa-
tion procedure (CABG);
 absence of haemodynamically significant val-
vular heart disease;
 the presence of appropriate technical condi-
tions for the performance of stress tests.
The study was approved by the Bioethics Com-
mittee of the Medical University of Bia‡ystok, Poland.
The degree of heart failure was evaluated on
the NYHA scale in accordance with the generally
accepted criteria and the clinical severity of coro-
nary artery disease was assessed according to the
Canadian Cardiovascular Society (CCS). The basic
demographic data and the characteristics of the
study group are summarised in Table 1.
On the basis of the clinical picture the patients
were qualified for coronary artery angiography com-
bined with ventriculography and then underwent
surgical revascularisation because of the presence
of multivessel disease. All the patients underwent
full coronary revascularisation and received typical
treatment for ischaemic heart disease in accordance
with current standards.
Course of the study
Resting echocardiography. Three to five
days before CABG two-dimensional transthoracic
echocardiography was performed in all the patients,
during which the classical parameters were meas-
ured in line with the recommendations of the Amer-
ican Society of Echocardiography. Echocardiogra-
phy was performed using the SONOS 5500 system
(Philips) with the S-3 probe (frequency range:
13 MHz, ultraband). Left ventricular contractility
Table 1. Patient characteristics.
Mean age (years) 60 – 9 (3975)
Body mass [kg] 82 – 13
Height [cm] 171 – 7
Body mass index 28 – 4 (2136)
Duration of CAD 6.5 years
(3 months  20 years)
A history of All the patients
myocardial infarction included in the study
Hypertension 20 (40%)
Diabetes mellitus 11 (22%)
Dyslipidaemia 36 (72%)
Smoking 24 (48%)
Family history of CAD 29 (58%)
NYHA class Mean: III – I
CCS class Mean: 3 – 1
Ejection fraction 34% – 4%
Wall motion score index 2 – 0,2
Number of affected All patients: 3 vessels
coronary vessels
CAD  coronary artery disease
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was evaluated by analysing the systolic increment
of the thickness of its walls, adopting a division into
16 segments in line with the recommendations of
the American Society of Echocardiography. During
the test the wall motion score index (WMSI) was
measured, assigning an appropriate score to each of
the three segments of each of the left ventricular walls
in accordance with the visual assessment [1  normo-
kinesis (normal contractility), 2  hypokinesis (re-
duced systolic thickening of the wall), 3  akine-
sis (no systolic thickening]. The WMSI was calcu-
lated by adding the scores assigned to specific
segments and dividing them by their number. Meas-
urements of the ejection fraction were performed
in the two-dimensional mode, using the biplane
Simpsons method and averaging the results from
three subsequent cardiac cycles.
Both parameters were evaluated during both
the resting tests and the stress test. Resting fol-
low-up tests were performed one week after sur-
gery and 3, 6 and 12 months after the procedure.
Echocardiography stress test. During the
three days before the test none of the patients re-
ceived drugs with a positive inotropic action. The
test with low-dose dobutamine (510 µg/kg/min)
was performed three or four days before CABG.
After recording four standard views in the resting
echo (long-axis parasternal view, short-axis par-
asternal view, four-chamber apical view and two-
chamber apical view) an intravenous infusion of
dobutamine was given. Six minutes after the infu-
sion had begun recording on a magneto-optic disk
was started. During the test and 10 minutes after
its completion pulse and blood pressure were mon-
itored. Discontinuation criteria were as follows:
a blood pressure drop of over 10% of the baseline
value, anginal pain, increasing dyspnoea and signif-
icant supraventricular and ventricular arrhythmias.
Contractility was evaluated by analysing the
systolic increment of wall thickness and left ven-
tricular ejection fraction. Both parameters were
evaluated at rest and following dobutamine. Myo-
cardial viability was defined as an improvement in
wall contractility of at least 1 point on the 4-point
scale of contractility. The test was considered pos-
itive if an improvement in contractility was achieved
in at least 4 segments.
Baseline images recorded before CABG were
compared with those recorded after the procedure
and at 3, 6 and 12 months. During the follow-up vis-
its the complications which made up the combined
endpoint (death, exacerbation of heart failure, ex-
acerbation of anginal symptoms and lack of improve-
ment in left ventricular function) were evaluated.
Statistical methods
The analysis was performed using the t-test for
matched and unmatched pairs or using the non-par-
ametric Wilcoxon test at the significance level of
< 0.05. Relative risk was defined as the incidence
of events in the group with abnormal test results
and the incidence of events in the group with nor-
mal test results. Multivariate logistic regression
was performed using the MedCalc 8.1.0.0 software
after the stepwise analysis had been established
with the elimination of factors with statistical sig-
nificance p > 0.05. The predictive value of each of
the factors (clinical, demographic and echocardio-
graphic) was analysed by the Kaplan-Meier method
according to the Cox model, using the standard
functions of the MedCalc 8.1.0.0 software. The sta-
tistical significance of the difference between the
curves was evaluated with the log-rank test.
Results
During the 12-month clinical follow-up 4 out of
50 patients died (8%). The main contributing fac-
tor was the perioperative mortality of 6% (3 deaths
during symptoms of increasing left ventricular fail-
ure and 1 death at 3 months following surgery
owing to severe left ventricular failure). Complications
occurred in 20 patients and included paroxysmal
atrial fibrillation in 14 (28%) patients and exacer-
bation of heart failure requiring hospitalisation in
6 (12%) patients. During the follow-up none of the
patients suffered myocardial reinfarction or re-
quired repeat revascularisation. One-year survival
beyond the perioperative period reached 98%.
Before the procedure most of the patients had
experienced anginal symptoms corresponding to
CCS classes II and III. One year after the procedure
26 patients manifested anginal symptoms in CCS
class I and 20 in CCS class II. None of the patients
experienced CCS class III or IV symptoms (Fig. 1).
At qualification for operation, 67% of the patients
(31 patients) had been in NYHA class III. A year
after revascularisation 17 patients were in NYHA
class I and 21 in NYHA class III (82% of the study
group). None of the patients in the study group
manifested heart failure symptoms in NYHA class IV
(Fig. 2).
No complications were observed during the
dobutamine stress tests. None of the patients de-
veloped pain and no ECG changes were observed.
Univariate and multivariate analysis
The analysis took into account demographic
(age and sex), clinical (the presence of coronary
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artery disease risk factors described in Table 1,
CCS class and NYHA class) and echocardiographic
(LVEF, WMSI) factors.
Both univariate and multivariate analysis dem-
onstrated that adverse prognosis following CABG
was affected by the following:
 a history of hypertension (p = 0.039) associat-
ed with a 4.9-fold higher risk of complications
(95% CI 1.417.1).
 lack of improvement in contractility in the do-
butamine stress echo test (p = 0.0003). Pa-
tients in whom improvement during the stress
test did not occur in at least 4 segments were
at a 37.2-fold higher risk of complications (95% CI
6.3218.4).
The survival curves for survival without com-
plications with or without a history of hypertension
are presented in Figure 3, while Figure 4 shows
survival relative to myocardial viability.
Figure 1. Change in CCS class from baseline at 1 year
following CABG (patients who completed the one-year
follow-up period are shown in the figure).
Figure 2. Change in NYHA class from baseline at 1 year
following CABG (patients who completed the one-year
follow-up period are shown in the figure).
Figure 3. Survival without complications during the one-
-year follow-up in patients with and without a history of
hypertension (HA), p = 0.039; a history of hypertension
was associated with a 4.9-fold higher risk of complica-
tions (95% CI 1.417.1).
Figure 4. Kaplan-Meier survival curves for survival
without complications over the one-year follow-up rela-
tive to the presence of viable myocardium in the dobu-
tamine stress test (the solid line represents an improve-
ment in contractility in at least 4 segments, while the
dotted line represents no improvement in contractility);
a 37.2-fold higher risk of complications (95% CI 6.3218.4;
p = 0.0003).
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Discussion
An increasing number of patients with coronary
heart disease and significant left ventricular dys-
function are being qualified for cardiac surgery.
Revascularisation of viable myocardium is associat-
ed with a good prognosis for improved resting ejec-
tion fraction [9]. The literature offers publications
assessing the value of the dobutamine test in pre-
dicting improvement in left ventricular function fol-
lowing CABG [9, 15]. There are, however, very few
reports on the value of the test in predicting the clin-
ical course, which was the subject of our study.
In our material the independent prognostic fac-
tors relating to the combined endpoint of death,
necessity of hospitalisation, exacerbation of angi-
nal symptoms and exacerbation of heart failure
turned out to be the following: a history of hyper-
tension and WMSI change following dobutamine.
Our findings are consistent with those obtained by
Bountioukos et al. [11], who found that hyperten-
sion, degree of contractility impairment during the
dobutamine test and the severity of heart failure
were independent prognostic factors for cardiac
adverse events.
Rizzello et al. [12] considered the following to
be independent prognostic factors: multivessel dis-
ease, WMSI change following dobutamine and left
ventricular viability. Over the five-year follow-up,
there were statistically less frequent cardiac deaths
and three-year survival was 77%. Liao et al. [13]
followed up for 2 years a group of 107 patients with
significant left ventricular dysfunction who had un-
dergone revascularisation following the stress tests.
Mortality in the group of patients in whom no viable
myocardium was found was significantly higher
(83.5% vs. 57.2%, p = 0.0037). Another factor affect-
ing poor prognosis was left ventricular end-systolic
pressure, as emphasised by Schinkel et al. [14] and
Afridi et al. [9]. In the latter study a cut-off point was
also the demonstration of viability of 4 segments in
which contractility had improved following dobutamine.
We found considerably fewer complications in
patients in whom contractility improvement in
a minimum of 4 segments was seen during the
stress test. Bax et al. [15] also demonstrated that
improvement in at least 4 segments reduced heart
failure in further follow-up.
In a study by Williams et al. [16] the independ-
ent prognostic factors, in addition to WMSI, were
age and baseline ejection fraction. According to Bou-
chart et al. [17], less favourable outcomes of surgi-
cal revascularisation were obtained in patients with
left ventricular enlargement and a higher NYHA
functional class. Chaudhry et al. [18] evaluated systo-
lic reserve using a low-dose dobutamine stress test
in patients with LVEF < 40%. In this study the NYHA
class and systolic reserve independently affected
cardiovascular mortality, while the left ventricular
ejection fraction did not reach statistical signifi-
cance. Pagano et al. [19] listed a low LVEF and
a small number of viable segments as predictors of
early cardiac death, with age, sex and NYHA class
playing no predictive role. In our group of patients
none of the parameters was found to be predictive
for death in the peri- and postoperative periods.
Owing to the small size of the group and the small
overall number of deaths, we did not evaluate the
effects of these parameters on mortality.
The small size of the study group, the obser-
vational nature of the study and the random selec-
tion of patients may be regarded as the limitations
of the work presented above.
Conclusions
1. Results of dobutamine stress echocardiography
in patients with a low left ventricular ejection
fraction were more predictive for clinical im-
provement than clinical and demographic pa-
rameters.
2. Patients with a negative stress test represent-
ed the subgroup with the gravest prognosis.
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